BridgeMD
Tests treatment safety and results for Type B Aortic Dissection
Official title Safety and Efficacy of Exercise in Type-B Aortic Dissection
ClinicalTrials.gov ID: NCT07009067
What this study is testing
- What it's testing
- This is a pilot study. The goal of this clinical trial is to evaluate the safety and efficacy of exercise-based cardiac rehabilitation in patients with Type-B Aortic dissection or intramural hematoma or penetrating ulcer and received endovascular repair.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients with a previous diagnosis of type B aortic dissection or intramural hematoma or penetrating ulcer, who underwent endovascular aortic repair...
- Able to independently carry out basic daily life activities, participants must be able to complete the baseline assessment and start the designated...
- Patients voluntarily participate in this study, sign the written informed consent, and are willing to cooperate with the follow-up;
You likely can't join if
- Acute myocardial infarction occurred 1 month ago;
- Combined with severe aortic stenosis or regurgitation;
- Combined with ascending aortic aneurysm or dissection;
- Acute heart failure occurred 2 weeks ago;
- Combined with severe hypertrophic obstructive cardiomyopathy;
- Chronic renal failure stage 5, which is defined as glomerular filtration rate \<15ml/(min 1.73m2) or dialysis;
See the full eligibility criteria
- Patients with a previous diagnosis of type B aortic dissection or intramural hematoma or penetrating ulcer, who underwent endovascular aortic repair (EVAR) or EVAR + supra-aortic shunt surgery for more than 1 month, and...
- Able to independently carry out basic daily life activities, participants must be able to complete the baseline assessment and start the designated treatment;
- Patients voluntarily participate in this study, sign the written informed consent, and are willing to cooperate with the follow-up;
- Acute myocardial infarction occurred 1 month ago;
- Combined with severe aortic stenosis or regurgitation;
- Combined with ascending aortic aneurysm or dissection;
- Acute heart failure occurred 2 weeks ago;
- Combined with severe hypertrophic obstructive cardiomyopathy;
- Chronic renal failure stage 5, which is defined as glomerular filtration rate \<15ml/(min 1.73m2) or dialysis;
- During the screening examination, the patient's alanine aminotransferase or aspartate aminotransferase is greater than or equal to 5 times the upper limit of the normal value specified by our center;
- Patients with any medical history that may affect compliance with the program;
- Patients with severe language, mental or physical disabilities who are unable to participate in the program;
- Pregnant or lactating women, or those with fertility who are unwilling/unable to take effective contraceptive measures;
- Patients participating in other treatment clinical trials;
- Patients with long-term high-intensity exercise habits;
- Patients who are judged by the researchers to be unsuitable for participation in this study;
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.